InvestorsHub Logo
Followers 30
Posts 2489
Boards Moderated 0
Alias Born 05/03/2012

Re: mrmainstreet post# 375654

Wednesday, 04/27/2022 11:23:32 AM

Wednesday, April 27, 2022 11:23:32 AM

Post# of 430192
I am still at $20 which is a steal for a big pharma but I would have to think hard at $18.

Why I say this is a steal……

They have Evaporate which I believe is enough to convince the FDA to add language on the label for plaque reduction and stabilization. This means anyone who receives a stent should also receive a script for Vascepa. That is for their lifetime. In the US that is huge…

From Reduce It, anyone who suffers a stroke or MI also should have a script.

The wild card is Alzheimer’s and I believe we will see some positive results.

Any big pharma can pull off the change to the label and you better believe they can figure out a way to tweak the formula to rebrand V for use other than high trigs to box out the generics.

We just have morons running the company.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News